Autofluorescence is a Reliable in vitro Marker of Cellular Senescence in Human Mesenchymal Stromal Cells

[1]  J. Masel,et al.  Intercellular competition and the inevitability of multicellular aging , 2017, Proceedings of the National Academy of Sciences.

[2]  J. Bao,et al.  Senescence of mesenchymal stem cells (Review). , 2017, International journal of molecular medicine.

[3]  J. Stoyanov,et al.  Oxidative status predicts quality in human mesenchymal stem cells , 2017, Stem cell research & therapeutics.

[4]  Xiao-Dong Su,et al.  Optimization of Reference Genes for Normalization of Reverse Transcription Quantitative Real-Time Polymerase Chain Reaction Results in Senescence Study of Mesenchymal Stem Cells. , 2016, Stem cells and development.

[5]  U. Galderisi,et al.  Clinical Trials with Mesenchymal Stem Cells: An Update , 2016, Cell transplantation.

[6]  A. Pezeshki,et al.  Naturally occurring p16Ink4a-positive cells shorten healthy lifespan , 2016, Nature.

[7]  S. Ferguson,et al.  An in vitro expansion score for tissue‐engineering applications with human bone marrow‐derived mesenchymal stem cells , 2016, Journal of tissue engineering and regenerative medicine.

[8]  Baojie Li,et al.  Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues , 2015, Experimental biology and medicine.

[9]  D. Jarocha,et al.  Continuous Improvement after Multiple Mesenchymal Stem Cell Transplantations in a Patient with Complete Spinal Cord Injury , 2015, Cell transplantation.

[10]  B. Gantenbein,et al.  In Vitro Cell Motility as a Potential Mesenchymal Stem Cell Marker for Multipotency , 2015, Stem cells translational medicine.

[11]  Kalina Belemezova,et al.  Secretion of immunoregulatory cytokines by mesenchymal stem cells. , 2014, World journal of stem cells.

[12]  M. Yen,et al.  RB Maintains Quiescence and Prevents Premature Senescence through Upregulation of DNMT1 in Mesenchymal Stromal Cells , 2014, Stem cell reports.

[13]  G. Bottiroli,et al.  Autofluorescence Spectroscopy and Imaging: A Tool for Biomedical Research and Diagnosis , 2014, European journal of histochemistry : EJH.

[14]  Manuel Hidalgo,et al.  Intracellular autofluorescence: a biomarker for epithelial cancer stem cells , 2014, Nature Methods.

[15]  Manuel Serrano,et al.  Cellular senescence: from physiology to pathology , 2014, Nature Reviews Molecular Cell Biology.

[16]  Anthony J. Cesare,et al.  A genomics approach identifies senescence-specific gene expression regulation , 2014, Aging cell.

[17]  J. Deursen The role of senescent cells in ageing , 2014, Nature.

[18]  David N. Rider,et al.  Telomere Length Varies By DNA Extraction Method: Implications for Epidemiologic Research , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[19]  B. Sola,et al.  A sensitive method to quantify senescent cancer cells. , 2013, Journal of visualized experiments : JoVE.

[20]  Yu-fang Shi,et al.  Mesenchymal stem cells: a new trend for cell therapy , 2013, Acta Pharmacologica Sinica.

[21]  David A. Gewirtz,et al.  Autophagy and senescence , 2013, Autophagy.

[22]  J. Bartek,et al.  Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues , 2012, Aging.

[23]  K. Eliceiri,et al.  Endogenous Fluorescence Signatures in Living Pluripotent Stem Cells Change with Loss of Potency , 2012, PloS one.

[24]  S. Ferguson,et al.  Influence of different commercial scaffolds on the in vitro differentiation of human mesenchymal stem cells to nucleus pulposus-like cells , 2012, European Spine Journal.

[25]  B. Sander,et al.  Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  I. Martin,et al.  Engineering of large osteogenic grafts with rapid engraftment capacity using mesenchymal and endothelial progenitors from human adipose tissue. , 2011, Biomaterials.

[27]  M. Fenech,et al.  A quantitative PCR method for measuring absolute telomere length , 2011, Biological Procedures Online.

[28]  K. Kwon,et al.  Evidences for correlation between the reduced VCAM-1 expression and hyaluronan synthesis during cellular senescence of human mesenchymal stem cells. , 2011, Biochemical and biophysical research communications.

[29]  David L. Kaplan,et al.  Two-Photon Microscopy for Non-Invasive, Quantitative Monitoring of Stem Cell Differentiation , 2010, PloS one.

[30]  J. Campisi,et al.  Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo , 2009, Nature Protocols.

[31]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[32]  S. Lowe,et al.  Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.

[33]  S. Raguz,et al.  Control of senescence by CXCR2 and its ligands , 2008, Cell cycle.

[34]  A. Reinisch,et al.  Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. , 2008, Tissue engineering. Part C, Methods.

[35]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[36]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[37]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[38]  J. Chan,et al.  Human First‐Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC , 2007, Stem cells.

[39]  D. DiMaio,et al.  Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase , 2006 .

[40]  Andrew Scutt,et al.  Aging of mesenchymal stem cells , 2006, Ageing Research Reviews.

[41]  V. Cristofalo SA β Gal staining: Biomarker or delusion , 2005, Experimental Gerontology.

[42]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[43]  U. Brunk,et al.  Lipofuscin: mechanisms of age-related accumulation and influence on cell function. , 2002, Free radical biology & medicine.

[44]  H. Rubin Promise and problems in relating cellular senescence in vitro to aging in vivo. , 2002, Archives of gerontology and geriatrics.

[45]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[46]  A. Terman Garbage catastrophe theory of aging: imperfect removal of oxidative damage? , 2001, Redox report : communications in free radical research.

[47]  D J Prockop,et al.  Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[49]  A. Brenner,et al.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.

[50]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Shay,et al.  Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. , 1994, Cancer research.

[52]  S. Bjornsson Simultaneous preparation and quantitation of proteoglycans by precipitation with Alcian blue , 1993 .

[53]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[54]  R Holliday,et al.  Autofluorescence as an index of ageing in human fibroblasts in culture , 1982, Bioscience reports.

[55]  R. Getty,et al.  Rate of accumulation of cardiac lipofuscin in the aging canine. , 1968, Journal of gerontology.

[56]  Jacques Galipeau,et al.  The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? , 2013, Cytotherapy.

[57]  D. DiMaio,et al.  Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. , 2006, Aging cell.

[58]  V. Cristofalo SA beta Gal staining: biomarker or delusion. , 2005, Experimental gerontology.